Daniela Maggioni

Dr. Daniela Maggioni

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2001 in Organometallics
Verified
Journal Article
Closed access
TBTiziana Beringhelli
Tiziana Beringhelli
DMDaniela Maggioni
Daniela Maggioni
GDGiuseppe D'Alfonso
Giuseppe D'Alfonso

2 October 2012 in Epilepsia
Verified
Journal Article
Open access
PDF file
MFMarta Filibian
Marta Filibian
AFAngelisa Frasca
Angelisa Frasca
DMDaniela Maggioni
Daniela Maggioni
EMEdoardo Micotti
Edoardo Micotti
AVAnnamaria Vezzani
Annamaria Vezzani
TRTeresa Ravizza
Teresa Ravizza
Summary: Purpose:  Long‐lasting activation of glia occurs in brain during epileptogenesis, which develops after various central nervous system (CNS) injuries. Glia is the cell source of the biosynthesis and release of molecules that play a role in seizure recurrence and may contribute to epileptogenesis, thus representing a putative biomarker of epilepsy development and severity. In this study, we set up an in vivo longitudinal study using 1H‐magnetic resonance spectroscopy (MRS) to measure metabolite content in the rat hippocampus that could reflect the extent and the duration of glia activation. Our aim was to explore if glia activation during epileptogenesis, or in the chronic epileptic phase, can be used as a biomarker of tissue epileptogenicity (i.e., a measure of epilepsy severity).Methods:  1H‐MRS measurements were done in the adult rat hippocampus every 24 h for 7 days after status epilepticus (SE) and in chronic epileptic rats, using a 7 T Bruker Biospec MRI (magnetic resonance imaging)/MRS scanner. We studied changes in metabolite levels that reflect astrocytes (myo‐inositol, mIns; glutathione, GSH), microglia/macrophage activation and the associated neuronal cell injury/dysfunction (lactate, Lac; N‐acetyl‐aspartate, NAA). 1H‐MRS results were validated by post hoc immunohistochemistry using cell‐specific markers. Data analysis was done to determine whether correlations exist between the metabolite changes and spontaneous seizure frequency or the extent of neuronal cell loss.Key Findings:  The analysis of 1H‐MRS spectra showed a progressive increase in mIns and GSH levels after SE, which was maintained in epileptic rats. Lac signal transiently increased during epileptogenesis being undetectable in chronic epileptic tissue. NAA levels were chronically reduced from day 2 post‐SE. Immunohistochemistry confirmed the activation of microglia and astrocytes and the progressive neuronal cell loss. GSH levels during epileptogenesis showed a negative correlation with the frequency of spontaneous seizures, whereas S100β levels in epileptic tissue were positively correlated with this outcome measure. A negative correlation was also found between GSH or mIns levels during epileptogenesis and the extent of neurodegeneration in hippocampus of epileptic rats.Significance:  1H‐MRS is a valuable in vivo technique for determining the extent and temporal profile of glia activation after an epileptogenic injury. S100β levels measured in the epileptic tissue may represent a biomarker of seizure frequency, whereas GSH levels during epileptogenesis could serve as a predictive marker of seizure frequency. Both mIns and GSH levels measured before the onset of spontaneous seizures predict the extent of neuronal cell loss in epileptic tissue. These findings highlight the potential of serial 1H‐MRS analysis for searching epilepsy biomarkers for prognostic, diagnostic, or therapeutic purposes.

26 April 2013 in Nano Letters
Verified
Journal Article
Closed access
SFStefano Freddi
Stefano Freddi
LSLaura Sironi
Laura Sironi
RDRocco D'Antuono
Rocco D'Antuono
DMDiego Morone
Diego Morone
ADAlice Donà
Alice Donà
Giuseppe ChiricoGiuseppe Chirico
Giuseppe Chirico

1 November 2008 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
TBTiziana Beringhelli
Tiziana Beringhelli
DDDaniela Donghi
Daniela Donghi
DMDaniela Maggioni
Daniela Maggioni
GDGiuseppe D’alfonso
Giuseppe D’alfonso

17 June 2005 in Inorganic Chemistry
Verified
Journal Article
Closed access
ASAlessia Di Saverio
Alessia Di Saverio
FFFrancesca Focante
Francesca Focante
ICIsabella Camurati
Isabella Camurati
LRLuigi Resconi
Luigi Resconi
TBTiziana Beringhelli
Tiziana Beringhelli
ASAngelo Sironi
Angelo Sironi

28 August 2019 in Chemistry of Materials
Verified
Journal Article
Open access
ARAniruddha Ray
Aniruddha Ray
DMDaniela Maggioni
Daniela Maggioni
DBDmitry Baranov
Dmitry Baranov
ZDZhiya Dang
Zhiya Dang
MPMirko Prato
Mirko Prato
AAAhmed L. Abdelhady
Ahmed L. Abdelhady
A detailed investigation into the synthesis of green-emitting powders of Cs4PbBr6 and CsPbBr3 materials by antisolvent precipitation from CsBr–PbBr2 precursor solutions in dimethylformamide (DMF) and dimethyl sulfoxide (DMSO) is reported. Various solvated lead bromide and polybromide species (PbBr2, [PbBr3]−, [PbBr4]2–, and possibly [PbBr5]3– or [PbBr6]4–) are detected in the precursor solutions by optical absorbance and emission spectroscopies. The solvodynamic size of the species in solution is strongly solvent-dependent: ∼1 nm species were detected in DMSO, while significantly larger species were observed in DMF by dynamic light scattering. The solvodynamic size of the lead bromide species plays a critical role in determining the Cs-Pb-Br composition of the precipitated powders: smaller species favor the precipitation of Cs4PbBr6, while larger species template the formation of CsPbBr3 under identical experimental conditions. The powders have been characterized by 133Cs and 207Pb solid-state nuclear magnetic resonance, and 133Cs sensitivity toward the different Cs environments within Cs4PbBr6 is demonstrated. Finally, the possible origins of green emission in Cs4PbBr6 samples are discussed. It is proposed that a two-dimensional Cs2PbBr4 inclusion may be responsible for green emission at ∼520 nm in addition to the widely acknowledged CsPbBr3 impurity, although we found no conclusive experimental evidence supporting such claims.